The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
£3.8m placing to ramp up the rollout of the products
Its been slow as they needed to raise. Now the raise is out the way, this will speed up things and within the next couple of the weeks the roll out will postive now
Looking for 20P in a short space of time
Msasively undervalued
Look at DEV CLEVER - did exctly the same
he Fundraising is conditional on, among other things, passing of the Resolutions by 4D shareholders at the General Meeting convened for 10:00 a.m. (GMT) on 18 March 2021 (the "General Meeting"), and completion of the merger with Longevity Acquisition Corporation (NASDAQ: LOAC) ("Longevity"), details of which were announced on 22 October 2020 (the "Merger"). Completion of the Merger, with admission of the Placing Shares to trading on AIM, and admission of the Consideration Shares to trading on NASDAQ as 4D American Depositary Shares ("ADSs") is expected to occur on 22 March 2021.
They have had their holding diluted by the PLACING - NOT SELLING
The listing in COPL will be cancelled as per the RTO and relisted on the standard list under a new ticker. This will take a few months to complete as the company will need to file registration documents with the listing company, and currently this take 3 months
Furthermore, pursuant to Listing Rule 5.6.19, an application to the Financial Conduct Authority ("FCA") for the cancellation of the Company's admission to the Official List and to the London Stock Exchange will be made imminently thereafter and it is expected that the Company's listing will be cancelled twenty business days thereafter in accordance with Listing Rule 5.2.8.
The Company intends to publish a prospectus relating to the enlarged entity following completion of the Proposed Transaction together with an application to the FCA and the London Stock Exchange for the common shares in the capital of the enlarged entity to be admitted to the standard segment of the Official List and to trading on the London Stock Exchange's Main Market for listed securities once the requisite financial information relating to Target has been consolidated and reported on an IFRS basis.
Warned everyone last week and yesterday that this will be suspened
3 months minimum
Need to get prospectus out and get the LSE to relist this
3 / 6 MONTHS
Hope you all listened
3/6 month suspension
Follow the news....
How do they finance it ??
Must have a share offering ?? placing
Finally Prelea is doing what he is employed to do
Delivering on expectations...
MM know this, so its upwards from Monday onwards
This should be £3.00 +++
Based on the prospectus and the future business, and looking across to its peers this should be commanding a £200m market cap.
Double from here
nm
Huge dilution to get through, plus hedge fund stock @£1.00 that Berenberg are trying to off load
so do we, before we can build on this momentum
Seen to be in the Cannabis market, and a major importer
We should be sitting at circa £30m market cap.
4 x times from here
Are going to be reversed in to Mountfield
Likely to the Cannabis play, based in Canada and Portugal
Importer of the flowers
Interesting play , with MASSIVE upside
Its called DILUTION....
nm
Massive for GLEN as the recovery is on its way
back to £3.10